| Author | Title | Source | Year |
| Chi-Ming Tai, Chun-Kai Huang, Te-Chang Changchien, et al. | Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic. | Viruses. 2022 Jul 27;14(8):1637. doi: 10.3390/v14081637. | 2022 |
| Yao-Chun Hsu, Cheng-Hao Tseng, Mindie H Nguye. | Reply. | Clin Gastroenterol Hepatol. 2022 Aug;20(8):1891-1892. doi: 10.1016/j.cgh.2021.10.026. | 2022 |
| Chu-Kuang Chou, Kun-Feng Tsai, Cheng-Hao Tseng, Ching-Tai Lee, Kuo-Hsin Yang, Min-Chi Chang, Chao-Wen Hsu. | Novel Colorectal Endoscopic Submucosal Dissection With Double-Endoscope and Snare-Based Traction. | Dis Colon Rectum. 2022 Jul 1;65(7):936-945. doi: 10.1097/DCR.0000000000002355. | 2022 |
| Yao-Chun Hsu, Chih-Cheng Chen, Wei-Hsiang Lee, Chi-Yang Chang, Fu-Jen Lee, Cheng-Hao Tseng, Tzu-Haw Chen, Hsiu J Ho, Jaw-Town Lin, Chun-Ying Wu. | Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents. | Sci Rep. 2022 Mar 31;12(1):5481. doi: 10.1038/s41598-022-09534-w. | 2022 |
| Cheng-Hao Tseng, Tzu-Haw Chen, Jia-Ling Wu, Teng-Yu Lee, John A Borghi, Jaw-Town Lin, Mindie H Nguyen, Yao-Chun Hsu. | Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis. | JHEP Rep. 2022 Oct 28;5(1):100617. doi: 10.1016/j.jhepr.2022.100617. | 2022 |
| Jen-Hao Yeh, Wen-Lun Wang, Chih-Wen Lin, Ching-Tai Lee, Cheng-Hao Tseng, Po-Jen Hsiao, Yu-Peng Liu, Jaw-Yuan Wang. | Safety of cold snare polypectomy with periprocedural antithrombotic agents for colorectal polyps: a systematic review and meta-analysis. | Therap Adv Gastroenterol. 2022 Feb 10;15:17562848211070717. doi: 10.1177/17562848211070717. | 2022 |
| Yao-Chun Hsu, Vithika Suri, Mindie H Nguyen, Yen-Tsung Huang, Chi-Yi Chen, I-Wei Chang, Cheng-Hao Tseng, Chun-Ying Wu, Jaw-Town Lin, David Z Pan, Anuj Gaggar, Ondrej Podlaha. | Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations with Implications on Host Gene Dysregulation. | Gastroenterology. 2022 Jan 4:S0016-5085(22)00006-3. doi: 10.1053/j.gastro.2021.12.286. | 2022 |
| Yao-Chun Hsu, Jia-Ling Wu, Cheng-Hao Tseng, Mindie H Nguyen, Chih-Wen Lin, Chih-Lung Hung. | Severe Acute Exacerbation after Cessation of Nucleos(t)ide Analog for Chronic Hepatitis B: a Real-world Study of Routine Practice. | Clin Gastroenterol Hepatol. 2022 Jun;20(6):1413-1415.e3. doi: 10.1016/j.cgh.2021.08.037. | 2022 |
| Hsu YC, Chen CY, Chang IW, Chang CY, Wu CY, Lee TY, Wu MS, Bair MJ, Chen JJ, Chen CC, Tseng CH, Tai CM, Huang YT, Ku WH, Mo LR, Lin JT. | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. | Lancet Infect Dis. 2021 Jun;21(6):823-833. doi: 10.1016/S1473-3099(20)30692-7. Epub 2021 Jan 29. Erratum in: Lancet Infect Dis. 2021 May;21(5):e122. | 2021 |
| Everson MA, Herrera LCGP, Wang HP, Lee CT, Chung CS, Hsieh PH, Chen CC, Tseng CH, Hsu MH, Vercauteren T, Ourselin S, Kashin S, Bisschops R, Pech O, Lovat L, Wang WL, Haidry RJ. | A clinically interpretable convolutional neural network for the real time prediction of early squamous cell cancer of the esophagus; comparing diagnostic performance with a panel of expert European and Asian endoscopists. | Gastrointest Endosc. 2021 Aug;94(2):273-281. doi: 10.1016/j.gie.2021.01.043. Epub 2021 Feb 5. | 2021 |
| Cheng-Hao Tseng, Chih-Cheng Chen, Chao-Ming Tseng, Ying-Nan Tsai, Chi-Zen Chen, Chong-Chi Chiu. | Comment on: C-reactive protein trajectory to predict colorectal anastomotic leak: PREDICT study. | Br J Surg. 2021 May 27;108(5):e209. doi: 10.1093/bjs/znab049. | 2021 |
| Nguyen MH, Atsukawa M, Ishikawa T, Yasuda S, Yokohama K, Trinh HN, Arai T, Fukunishi S, Ogawa E, Hsu YC, Maeda M, Dang H, Tseng CH, Takahashi H, Jun DW, Watanabe T, Chuma M, Nozaki A, Kawada N, Cheung R, Enomoto M, Takaguchi K, Toyoda H. | Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir. | Am J Gastroenterol. 2021 Jun 1;116(6):1264-1273. doi: 10.14309/ajg.0000000000001157. | 2021 |
| Yao-Chun Hsu, Cheng-Hao Tseng, Yen-Tsung Huang, Hwai-I Yang. | Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective. | Semin Liver Dis. 2021 Aug;41(3):285-297. doi: 10.1055/s-0041-1730924. | 2021 |
| Yeh ML, Liang PC, Tsai PC, Wang SC, Leong J, Ogawa E, Jun DW, Tseng CH, Landis C, Tanaka Y, Huang CF, Hayashi J, Hsu YC, Huang JF, Dai CY, Chuang WL, Nguyen MH, Yu ML. | Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR. | Cancers (Basel). 2021 Jul 9;13(14):3455. doi: 10.3390/cancers13143455. | 2021 |
| Cheng-Hao Tseng, Yao-Chun Hsu, Hsiu J Ho, Mindie H Nguyen, Chun-Ying Wu. | Increasing Age and Nonliver Comorbidities in Patients with Chronic Hepatitis B in Taiwan: A Nationwide Population-Based Analysis. | Dig Dis. 2021;39(3):266-274. doi: 10.1159/000511585. Epub 2020 Sep 15. | 2021 |
| Yao-Chun Hsu, Cheng-Hao Tseng, Tung-Hung Su, Jia-Horng Kao, Mindie H Nguyen. | Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. | Gut. 2021 Oct 20:gutjnl-2021-326232. doi: 10.1136/gutjnl-2021-326232. Epub ahead of print. | 2021 |
| Yao-Chun Hsu, Cheng-Hao Tseng, Mindie H Nguyen. | Lurking in acute hepatitis B flares following treatment cessation were inescapable uncertainty and potential irreversibility. | Clin Gastroenterol Hepatol. 2021 Oct 19:S1542-3565(21)01139-3. doi: 10.1016/j.cgh.2021.10.026. Epub ahead of print. | 2021 |
| Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen. | Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. | Lancet Gastroenterol Hepatol. 2021 Feb;6(2):87-88. doi: 10.1016/S2468-1253(20)30395-2. | 2021 |
| Matt Liu, Tai-Chung Tseng, Dae Won Jun, et al. | Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. | Hepatol Int. 2021 Feb;15(1):71-81. doi: 10.1007/s12072-020-10113-2. | 2021 |
| Sung-Nan Pei, Chun-Kai Liao, Yaw-Sen Chen, Cheng-Hao Tseng, Chao-Ming Hung, Chong-Chi Chiu6, Meng-Che Hsieh, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Kun-Ming Rau. | A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study. | Cancers (Basel). 2021 Jul 29;13(15):3831. | 2021 |
| Jen-Hao Yeh, Cheng-Hao Tseng, Ru-Yi Huang, Chih-Wen Lin, Ching-Tai Lee, Po-Jen Hsiao, Tsung-Chin Wu, Liang-Tseng Kuo, Wen-Lun Wang. | Long-term Outcomes of Primary Endoscopic Resection vs Surgery for T1 Colorectal Cancer: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol. 2020 Nov;18(12):2813-2823.e5. doi: 10.1016/j.cgh.2020.05.060. Epub 2020 Jun 8. PMID: 32526343. | 2020 |
| Tseng CH, Hsu YC, Chen TH, Ji F, Chen IS, Tsai YN, Hai H, Thuy LTT, Hosaka T, Sezaki H, Borghi JA, Cheung R, Enomoto M, Nguyen MH. | Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. | Lancet Gastroenterol Hepatol. 2020 Sep 29:S2468-1253(20)30249-1. doi: 10.1016/S2468-1253(20)30249-1. Epub ahead of print. PMID: 33007228. | 2020 |
| Chao-Ming Tseng, Hsi-Hao Wang, Wen-Lun Wang, Ching-Tai Lee, Chi-Ming Tai, Cheng-Hao Tseng, Chih-Cheng Chen, Ying-Nan Tsai, Meng-Shun Sun, Yao-Chun Hsu | Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer. | Endocr Pract. 2020 Jul;26(7):707-713. doi: 10.4158/EP-2019-0565. Epub 2020 Nov 24. | 2020 |
| Chen CC, Luo JC, Fang YJ, et al. | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial. | Therap Adv Gastroenterol. 2020 Jul 31;13:1756284820927306. doi: 10.1177/1756284820927306. PMID: 32821287; PMCID: PMC7406927. | 2020 |
| Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen. | Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. | Lancet Gastroenterol Hepatol. 2021 Feb;6(2):87-88. doi: 10.1016/S2468-1253(20)30395-2. | 2020 |
| Ogawa E, Toyoda H, Iio E, et al. | Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication. | Clin Infect Dis. 2020 Dec 31;71(11):2840-2848. doi: 10.1093/cid/ciz1160. | 2020 |
| Cheng-Hao Tseng, Mindie H Nguyen, Yao-Chun Hsu. | Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on. | Hepatol Int. 2020 Sep;14(5):886-887. doi: 10.1007/s12072-020-10080-8. Epub 2020 Aug 13. | 2020 |
| Chao-Ming Tseng, Hsi-Hao Wang, Ching-Tai Lee, Chi-Ming Tai, Cheng-Hao Tseng, Chih-Cheng Chen, Ying-Nan Tsai, Tzu-Haw Chen, Ming-Hung Hsu, Chih-Chun Wang, Tzer-Zen Hwang, Hsiu-Po Wang, Wen-Lun Wang. | A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors. | Sci Rep. 2020;10(1):884. Published 2020 Jan 21. doi:10.1038/s41598-020-57630-6 | 2020 |
| Cheng-Hao Tseng, Chao-Ming Tseng, Jia-Ling Wu, Yao-Chun Hsu, Hashem B El-Serag. | Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review. | J Gastroenterol Hepatol. 2020 Oct;35(10):1684-1693. doi: 10.1111/jgh.15078. Epub 2020 May 17. PMID: 32343431. | 2020 |
| Yao-Chun Hsu4, Mindie H Nguyen, Lein-Ray Mo, Ming-Shiang Wu, Tzeng-Huey Yang, Chieh-Chang Chen, Cheng-Hao Tseng, Chi-Ming Tai, Chun-Ying Wu, Jaw-Town Lin, Yasuhito Tanaka, Chi-Yang Chang. | Combining Hepatitis B Core-Related and Surface Antigens at End of Nucleos(t)ide Analogue Treatment to Predict Off-Therapy Relapse Risk | Aliment Pharmacol Ther. 2019;49(1):107–115. doi:10.1111/apt.15058 | 2019 |
| Cheng-Hao Tseng, Chih-Kun Huang, Tzu-Haw Chen, Ming-Hung Hsu, I-Sung Chen, Chi-Ming Tai. | Increase in erosive esophagitis after laparoscopic adjustable
gastric banded plication | Adv Dig Med. 2019;6:69–72. | 2019 |
| Hsu YC, Tseng CH, Kao JH. | Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done. | Clin Gastroenterol Hepatol. 2019 Apr;17(5):1000-1001. doi: 10.1016/j.cgh.2018.09.002. | 2019 |
| Jun T, Hsu YC, Ogawa S, Huang YT, Yeh ML, Tseng CH, Huang CF, Tai CM, Dai CY, Huang JF, Chuang WL, Yu ML, Tanaka Y, Nguyen MH. | Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection. | Hepatol Commun. 2019 Feb 8;3(4):493-503. doi: 10.1002/hep4.1321. eCollection 2019 Apr. | 2019 |
| Tai CM, Yen YC, Bair MJ, Tseng CH, Chang TT, Huang CF, Yeh ML, Dai CY, Chuang WL, Yu ML, Huang JF. | Integrated care for methadone maintenance patients with hepatitis C virus infection. | Kaohsiung J Med Sci. 2019 May 14. doi: 10.1002/kjm2.12086. [Epub ahead of print] | 2019 |
| Wang WL, Chang IW, Chen CC, Chang CY, Tseng CH, Tai CM, Lin JT, Wang HP, Lee CT. | Lessons from pathological analysis of recurrent early esophageal squamous cell neoplasia after complete endoscopic radiofrequency ablation. | Endoscopy. 2018;50(8):743–750. doi:10.1055/s-0044-101352 | 2018 |
| Cheng-Hao Tseng, Chi-Yang Chang, Lein-Ray Mo, Jaw-Town Lin, Chi-Ming Tai, Daw-Shyong Perng, Chih-Wen Lin, Yao-Chun Hsu. | Acoustic Radiation Force Impulse Elastography With APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients. | Ann Hepatol. 2018;17(5):789–794. doi:10.5604/01.3001.0012.3137 | 2018 |
| Wang WL, Chang IW, Chen CC, Chang CY, Tseng CH, Tai CM, Lin JT, Wang HP, Lee CT. | The in vivo tissue effect of endoscopic balloon-based radiofrequency ablation in treating esophageal squamous cell neoplasia. | United European Gastroenterol J. 2018 Jun;6(5):656-661. doi: 10.1177/2050640618755236. Epub 2018 Feb 2. | 2018 |
| Chen YN, Chang LC, Chang CY, Chen PJ, Chen CY, Tseng CH, Chiu HM. | Comparison of cold and hot snaring polypectomy for small colorectal polyps: study protocol for a randomized controlled trial. | Trials. 2018 Jul 6;19(1):361. doi: 10.1186/s13063-018-2743-z. | 2018 |
| Tseng CM, Liao WC, Chang CY, Lee CT, Tseng CH, Hsu YC, Lin JT. | Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan. | Pancreatology. 2017 Jan - Feb;17(1):76-82. doi: 10.1016/j.pan.2016.10.003. Epub 2016 Oct 7. | 2017 |
| Tseng CH1, Hsu YC2, Chang CY3, Tseng TC4, Wu MS4, Lin JT3, Kao JH5. | Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B. | J Formos Med Assoc. 2017 Dec 14. pii: S0929-6646(17)30462-X. doi: 10.1016/j.jfma.2017.11.012. [Epub ahead of print] | 2017 |
| Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT. | Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. | J Gastroenterol Hepatol. 2017 Aug;32(8):1512-1519. doi: 10.1111/jgh.13728. | 2017 |
| Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM1, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY. | Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. | PLoS One. 2016 Dec 9;11(12):e0167815. doi: 10.1371/journal.pone.0167815. eCollection 2016. | 2016 |
| Liou JM, Fang YJ, Chen CC, et al. | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. | Lancet. 2016 Nov 12;388(10058):2355-2365. doi: 10.1016/S0140-6736(16)31409-X. Epub 2016 Oct 18. | 2016 |
| Liou JM, Fang YJ, Chen CC, et al. | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. | Lancet. 2016 Oct 18. pii: S0140-6736(16)31409-X. doi: 10.1016/S0140-6736(16)31409-X. [Epub ahead of print] | 2016 |
| Liou JM, Bair MJ, Chen CC, Lee YC, Chen MJ, Chen CC, Tseng CH, Fang YJ, Lee JY, Yang TH, Luo JC, Wu JY, Chang WH, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hung HW, Lin JT, Chang CY, Wu MS. | Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial. | Am J Gastroenterol. 2016 Mar;111(3):381-7. doi: 10.1038/ajg.2015.439. Epub 2016 Feb 2. | 2016 |
| Liou JM, Chang CY, Chen MJ, Chen CC, Fang YJ, Lee JY, Wu JY, Luo JC, Liou TC, Chang WH, Tseng CH, Wu CY, Yang TH, Chang CC, Wang HP, Sheu BS, Lin JT, Bair MJ, Wu MS1; Taiwan Gastrointestinal Disease and Helicobacter Consortium. | The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study. | PLoS One. 2015 May 5;10(5):e0124199. doi: 10.1371/journal.pone.0124199. eCollection 2015. | 2015 |
| Liou JM, Chen CC, Chang CY, et al. | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial. | Gut. 2015 Sep 3. pii: gutjnl-2015-310142. doi: 10.1136/gutjnl-2015-310142. [Epub ahead of print] | 2015 |
| Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR. | Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B. | J Antimicrob Chemother. 2014 Jul;69(7):1920-7. doi: 10.1093/jac/dku041. Epub 2014 Feb 26. | 2014 |
| Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Helicobacter Consortium. | Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. | Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16. | 2013 |
| Wang WL, Wang CP, Wang HP, Lee CT, Chang CY, Tai CM, Tseng CH, Hwang TZ, Wang CC, Lo JL, Tseng PH, Chiu HM, Lee JM, Ko JY, Lou PJ, Wu MS, Lee YC, Lin JT. | The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer. | Oral Oncol. 2013 Aug;49(8):808-13. doi: 10.1016/j.oraloncology.2013.04.009. Epub 2013 May 18. | 2013 |
| Lee CT, Chang CY, Tai CM, Wang WL, Tseng CH, Hwang JC, Lin JT. | Endoscopic submucosal dissection for early esophageal neoplasia: a single center experience in South Taiwan. | J Formos Med Assoc. 2012 Mar;111(3):132-9. Epub 2012 Feb 8. | 2012 |
| Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT. | Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation. | Antivir Ther. 2012;17(4):605-12. doi: 10.3851/IMP2027. Epub 2011 Dec 20. | 2012 |
| Hsieh MJ, Lee TC, Tseng CH, Lin TH, Liu KL, Chen SY, Wang HP. | Duodenum-penetrating toothpick with liver abscess: removal with single-balloon enteroscopy. | Endoscopy. 2011;43 Suppl 2:E11-2. Epub 2011 Jan 26. | 2011 |
| Tseng CH, Liou JM, Liu KL, Wang HP. | A 61-year-old man with abdominal pain for 6 months | Gut. 2010 Feb;59(2):147, 185. | 2010 |
| Tai CM, Wang HP, Lee CT, Chang CY, Wang WL, Tseng CH, Lin JT. | Esophageal obstruction by a tangled nasogastric tube. | Gastrointest Endosc. 2010 Nov;72(5):1057-8. | 2010 |